News

Chemo-IO in early-stage NSCLC: adjuvant or perioperative?

SWOG's leadership team includes three new-ish executive officers

2026 marks 70 years since the founding of the research group that would become SWOG

Dr. Jonathan W. Friedberg transformed SWOG lymphoma research

Announced at our spring meeting: The Dr. Charles D. Blanke Veterans’ Access to Clinical Trials Initiative

Protocol-specific initial order builds for all SWOG treatment trials